Zobrazeno 1 - 10
of 61
pro vyhledávání: '"C. McCrary Sisk"'
Publikováno v:
International Journal of Clinical Practice. 67:297-302
Summary Background: This post hoc analysis from the Coronary Drug Project (CDP) evaluated the effects of niacin vs. placebo on the incidence of new onset type 2 diabetes mellitus (T2DM) and cardiovascular event rates in patients with normal and impai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::79dc3a15c11c25e640e8e4bfeddfc5a0
https://doi.org/10.1111/ijcp.12089
https://doi.org/10.1111/ijcp.12089
Publikováno v:
International Journal of Clinical Practice. 65:436-445
Summary Background: In patients with primary hypercholesterolemia or mixed dyslipidemia, extended-release niacin/laropiprant (ERN/LRPT) improves key lipid parameters associated with increased atherosclerotic coronary heart disease (CHD) risk. Aim: Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b92e3f9d94d6e54e2c5a7cebe2712609
https://doi.org/10.1111/j.1742-1241.2010.02620.x
https://doi.org/10.1111/j.1742-1241.2010.02620.x
Autor:
H. Giezek, Alice R. Mao, S. Shah, Richard Ceska, C. McCrary Sisk, J. F. Paolini, B. Gil-Extremera, K. Vandormael, Darbie Maccubbin
Publikováno v:
International Journal of Clinical Practice. 64:727-738
Summary Background: Co-administration of niacin with statin offers the potential for additional lipid management and cardiovascular risk reduction. However, niacin is underutilised because of the side effects of flushing, mediated primarily by prosta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7b573da24158755998293742982d462
https://doi.org/10.1111/j.1742-1241.2010.02370.x
https://doi.org/10.1111/j.1742-1241.2010.02370.x
Autor:
John F. Paolini, Abigaile Betteridge, Anders G. Olsson, Robert Reyes, A. Elis, C. McCrary Sisk, Qinfen Yu, Harold E. Bays, Waheeda Sirah, Olga M. Kuznetsova, Richard C. Pasternak, Darbie Maccubbin, V. Elinoff, Yale B. Mitchel
Publikováno v:
International Journal of Clinical Practice. 62:1959-1970
Summary Background: Improving lipids beyond low-density lipoprotein cholesterol (LDL-C) lowering with statin monotherapy may further reduce cardiovascular risk. Niacin has complementary lipid-modifying efficacy to statins and cardiovascular benefit,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7b45ac1704417c2a1a82326009d07d8b
https://doi.org/10.1111/j.1742-1241.2008.01938.x
https://doi.org/10.1111/j.1742-1241.2008.01938.x
Autor:
Enrico P. Veltri, C. A. Dujovne, Darbie Maccubbin, C. McCrary Sisk, John Strony, Ramachandran Suresh
Publikováno v:
International Journal of Clinical Practice. 62:1332-1336
Summary Aims: This report examined the safety and efficacy of treatment for up to 2 years with the cholesterol absorption inhibitor, ezetimibe (EZE). Methods: Two identical, randomised, double-blind trials (starting with 827 and 892 patients), evalua
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a748e6d0fc51e152fa84ec49e38d6d44
https://doi.org/10.1111/j.1742-1241.2008.01798.x
https://doi.org/10.1111/j.1742-1241.2008.01798.x
Autor:
Gerald Salen, Waheeda Sirah, C. McCrary Sisk, K. von Bergmann, Thomas Musliner, Dieter Lütjohann, Aditi Sapre, D. Cselovszky
Publikováno v:
International Journal of Clinical Practice. 62:995-1000
Summary Objective: To assess the effect of ezetimibe (EZE) 40 mg/day on non-cholesterol sterol plasma concentrations in patients with homozygous sitosterolaemia (HoS). Methods: This was a multi-centre, randomised, double-blind, placebo-controlled par
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7c24c6c2dfd9ad18f18cacd959bd4cbf
https://doi.org/10.1111/j.1742-1241.2008.01786.x
https://doi.org/10.1111/j.1742-1241.2008.01786.x
Autor:
S. Westphal, C. Constance, M. Lund, Namsik Chung, C. McCrary Sisk, C. Allen, Amy O. Johnson-Levonas, R. Massaad
Publikováno v:
Diabetes, Obesity and Metabolism. 9:575-584
This randomized, double-blind study evaluated the efficacy of switching from atorvastatin (ATV) 10 mg to ezetimibe/simvastatin (EZE/SIMVA) 10/20 mg, EZE/SIMVA 10/40 mg or doubling the dose of ATV from 10 to 20 mg in patients with type 2 diabetes (T2D
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::615cf579c6db12a78631de517e284a6d
https://doi.org/10.1111/j.1463-1326.2007.00725.x
https://doi.org/10.1111/j.1463-1326.2007.00725.x
Autor:
C. McCrary Sisk, Douglas J. Watson, Darbie Maccubbin, Josephine M. Norquist, A. Trovato, Thomas Rhodes, J. Liao, Kelly McQuarrie, T. Miller
Publikováno v:
International journal of clinical practice. 67(12)
SummaryBackground Niacin has lipid-modifying efficacy and cardiovascular benefit, but is underutilised because of niacin-induced flushing (NIF). This real-world, prospective, observational study characterised the severity and impact of NIF symptoms a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::063bda6ec551d92385cc66f8204d40d9
https://pubmed.ncbi.nlm.nih.gov/24102896
https://pubmed.ncbi.nlm.nih.gov/24102896
Publikováno v:
International journal of clinical practice. 65(4)
In patients with primary hypercholesterolemia or mixed dyslipidemia, extended-release niacin/laropiprant (ERN/LRPT) improves key lipid parameters associated with increased atherosclerotic coronary heart disease (CHD) risk.This analysis examined data
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d7f999a2875be945812121f3447a0ab1
https://pubmed.ncbi.nlm.nih.gov/21401833
https://pubmed.ncbi.nlm.nih.gov/21401833
Autor:
D, Maccubbin, H E, Bays, A G, Olsson, V, Elinoff, A, Elis, Y, Mitchel, W, Sirah, A, Betteridge, R, Reyes, Q, Yu, O, Kuznetsova, C McCrary, Sisk, R C, Pasternak, J F, Paolini
Publikováno v:
International journal of clinical practice. 62(12)
Improving lipids beyond low-density lipoprotein cholesterol (LDL-C) lowering with statin monotherapy may further reduce cardiovascular risk. Niacin has complementary lipid-modifying efficacy to statins and cardiovascular benefit, but is underutilised
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::70f8bc91020bde981a215d6c86618fd2
https://pubmed.ncbi.nlm.nih.gov/19166443
https://pubmed.ncbi.nlm.nih.gov/19166443